S&P 500   4,221.48 (+0.27%)
DOW   33,429.96 (+0.36%)
QQQ   325.87 (-0.02%)
AAPL   169.22 (-0.01%)
MSFT   288.35 (-0.28%)
META   178.24 (-0.06%)
GOOGL   119.37 (-0.28%)
AMZN   141.14 (-1.09%)
TSLA   869.72 (-1.51%)
NVDA   181.28 (+0.17%)
NIO   21.12 (+5.34%)
BABA   94.93 (+2.70%)
AMD   99.45 (+0.40%)
MU   62.95 (+2.52%)
T   18.10 (+0.50%)
CGC   3.18 (-3.34%)
GE   78.99 (+2.40%)
F   15.87 (+2.39%)
DIS   118.52 (+5.42%)
AMC   25.02 (+5.70%)
PYPL   99.75 (+0.85%)
PFE   48.13 (-3.64%)
NFLX   244.66 (+0.23%)
S&P 500   4,221.48 (+0.27%)
DOW   33,429.96 (+0.36%)
QQQ   325.87 (-0.02%)
AAPL   169.22 (-0.01%)
MSFT   288.35 (-0.28%)
META   178.24 (-0.06%)
GOOGL   119.37 (-0.28%)
AMZN   141.14 (-1.09%)
TSLA   869.72 (-1.51%)
NVDA   181.28 (+0.17%)
NIO   21.12 (+5.34%)
BABA   94.93 (+2.70%)
AMD   99.45 (+0.40%)
MU   62.95 (+2.52%)
T   18.10 (+0.50%)
CGC   3.18 (-3.34%)
GE   78.99 (+2.40%)
F   15.87 (+2.39%)
DIS   118.52 (+5.42%)
AMC   25.02 (+5.70%)
PYPL   99.75 (+0.85%)
PFE   48.13 (-3.64%)
NFLX   244.66 (+0.23%)
S&P 500   4,221.48 (+0.27%)
DOW   33,429.96 (+0.36%)
QQQ   325.87 (-0.02%)
AAPL   169.22 (-0.01%)
MSFT   288.35 (-0.28%)
META   178.24 (-0.06%)
GOOGL   119.37 (-0.28%)
AMZN   141.14 (-1.09%)
TSLA   869.72 (-1.51%)
NVDA   181.28 (+0.17%)
NIO   21.12 (+5.34%)
BABA   94.93 (+2.70%)
AMD   99.45 (+0.40%)
MU   62.95 (+2.52%)
T   18.10 (+0.50%)
CGC   3.18 (-3.34%)
GE   78.99 (+2.40%)
F   15.87 (+2.39%)
DIS   118.52 (+5.42%)
AMC   25.02 (+5.70%)
PYPL   99.75 (+0.85%)
PFE   48.13 (-3.64%)
NFLX   244.66 (+0.23%)
S&P 500   4,221.48 (+0.27%)
DOW   33,429.96 (+0.36%)
QQQ   325.87 (-0.02%)
AAPL   169.22 (-0.01%)
MSFT   288.35 (-0.28%)
META   178.24 (-0.06%)
GOOGL   119.37 (-0.28%)
AMZN   141.14 (-1.09%)
TSLA   869.72 (-1.51%)
NVDA   181.28 (+0.17%)
NIO   21.12 (+5.34%)
BABA   94.93 (+2.70%)
AMD   99.45 (+0.40%)
MU   62.95 (+2.52%)
T   18.10 (+0.50%)
CGC   3.18 (-3.34%)
GE   78.99 (+2.40%)
F   15.87 (+2.39%)
DIS   118.52 (+5.42%)
AMC   25.02 (+5.70%)
PYPL   99.75 (+0.85%)
PFE   48.13 (-3.64%)
NFLX   244.66 (+0.23%)
NYSE:MDT

Medtronic - MDT Stock Forecast, Price & News

$94.47
+0.30 (+0.32%)
(As of 08/11/2022 02:04 PM ET)
Add
Compare
Today's Range
$94.19
$94.97
50-Day Range
$87.40
$98.50
52-Week Range
$86.70
$135.89
Volume
235,633 shs
Average Volume
4.45 million shs
Market Capitalization
$126.74 billion
P/E Ratio
25.33
Dividend Yield
2.92%
Price Target
$117.13

Medtronic MarketRank™ Forecast

Analyst Rating
Hold
2.45 Rating Score
Upside/​Downside
24.2% Upside
$117.13 Price Target
Short Interest
Healthy
0.73% of Float Sold Short
Dividend Strength
Strong
Based on Four Factors
Sustainability
-0.81
Upright™ Environmental Score
News Sentiment
-0.25mentions of Medtronic in the last 14 days
Based on 3 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
8.09%
From $5.56 to $6.01 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

3.00 out of 5 stars

Medical Sector

29th out of 1,112 stocks

Electromedical Equipment Industry

1st out of 24 stocks

MDT stock logo

About Medtronic (NYSE:MDT) Stock

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and products. The company's Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure, electrosurgery products, surgical artificial intelligence and robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology and lung products, and various therapies to treat diseases, as well as products in the fields of minimally invasive gastrointestinal and hepatologic diagnostics and therapies, patient monitoring, airway management and ventilation therapies, and renal disease. Its Neuroscience Portfolio segment offers products for spinal surgeons; neurosurgeons; neurologists; pain management specialists; anesthesiologists; orthopedic surgeons; urologists; urogynecologists; interventional radiologists; ear, nose, and throat specialists; and systems that incorporate energy surgical instruments. It also provides image-guided surgery and intra-operative imaging systems and robotic guidance systems used in robot assisted spine procedures; and therapies for vasculature in and around the brain. The company's Diabetes Operating Unit segment offers insulin pumps and consumables, continuous glucose monitoring systems, smart insulin pen systems, and consumables and supplies. The company was founded in 1949 and is headquartered in Dublin, Ireland.

Analysts Set New Price Targets

Several equities research analysts have recently commented on the stock. Atlantic Securities lowered shares of Medtronic from an "overweight" rating to a "neutral" rating and reduced their price target for the company from $125.00 to $105.00 in a report on Wednesday, June 1st. Deutsche Bank Aktiengesellschaft cut their price objective on shares of Medtronic from $149.00 to $121.00 in a research report on Friday, May 27th. Sanford C. Bernstein reaffirmed a "buy" rating and issued a $122.00 price objective on shares of Medtronic in a research report on Friday, May 20th. Wolfe Research assumed coverage on shares of Medtronic in a research report on Tuesday, July 5th. They issued an "underperform" rating and a $85.00 price objective on the stock. Finally, Needham & Company LLC downgraded shares of Medtronic from a "buy" rating to a "hold" rating in a research report on Friday, May 27th. One investment analyst has rated the stock with a sell rating, ten have issued a hold rating and twelve have issued a buy rating to the stock. According to MarketBeat.com, Medtronic currently has an average rating of "Hold" and a consensus price target of $117.13.

Medtronic Stock Performance

MDT opened at $94.17 on Thursday. The company has a debt-to-equity ratio of 0.39, a current ratio of 1.86 and a quick ratio of 1.49. The firm has a fifty day moving average price of $91.24 and a 200 day moving average price of $100.64. Medtronic has a 1 year low of $86.70 and a 1 year high of $135.89. The stock has a market cap of $126.33 billion, a P/E ratio of 25.25, a P/E/G ratio of 2.39 and a beta of 0.75.

Medtronic (NYSE:MDT - Get Rating) last posted its earnings results on Thursday, May 26th. The medical technology company reported $1.52 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.56 by ($0.04). Medtronic had a net margin of 15.90% and a return on equity of 14.50%. The firm had revenue of $8.09 billion during the quarter, compared to analyst estimates of $8.43 billion. During the same quarter in the prior year, the firm earned $1.50 earnings per share. The business's revenue for the quarter was down 1.2% on a year-over-year basis. Equities research analysts anticipate that Medtronic will post 5.56 earnings per share for the current year.

Medtronic Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, July 15th. Investors of record on Friday, June 24th were paid a $0.68 dividend. This is a boost from Medtronic's previous quarterly dividend of $0.63. This represents a $2.72 annualized dividend and a dividend yield of 2.89%. The ex-dividend date of this dividend was Thursday, June 23rd. Medtronic's payout ratio is currently 72.92%.

Receive MDT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Medtronic and its competitors with MarketBeat's FREE daily newsletter.

MDT Stock News Headlines

Are Medtronic And Intuitive Surgical Poised For Big Growth?
Health care is one of the better-performing sectors in 2022, with medical gear makers Medtronic and Intuitive Surgical outpacing the broader industry recently.
MarketBeat: Week in Review 7/25 – 7/29 (MDT)
The markets are rallying as big tech earnings are lifting investors' spirits. Here are some of the stocks our analysts were looking at this week.
27 U.S. Cities Where Stocks Yield 26% a Year
What’s the highest-yielding stock you’ve ever owned? The dividends for these stocks have risen so fast over the years that they’re now yielding us an average of 26%! When you start getting paid 26% on your money, your financial problems tend to pretty much evaporate. pixel
Medtronic Stock Keeps Ticking Forward
Medical device maker Medtronic (NYSE: MDT) stock is trading down (-14%) for the year.
Abbott Labs Stock Can Be a Recession Hedge for Your Portfolio (MDT)
Diversified global medical science products maker Abbott (NYSE: ABT) stock is down a modest (-11.5%) on the year. Abbott provides full lifecycle health and medical products from baby formula to nutrition supplement products, chronic disease treatments and medical devices to generic pharmaceuticals
Medtronic (NYSE:MDT) Downgraded by TheStreet
Biden & Bill Gates Igniting $40 Trillion Heist?
Has President Biden’s new executive order… Alongside MIT, 77 global Governments, The Gates Foundation, UNICEF, and The Clinton Development Initiative… Ignited a historic $40 trillion transfer of wealth from the middle class, to the rich?
Medtronic (NYSE:MDT) PT Lowered to $97.00
See More Headlines
Receive MDT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Medtronic and its competitors with MarketBeat's FREE daily newsletter.

MDT Company Calendar

Last Earnings
5/26/2022
Ex-Dividend for 7/15 Dividend
6/23/2022
Dividend Payable
7/15/2022
Today
8/11/2022
Next Earnings (Confirmed)
8/23/2022
Fiscal Year End
4/30/2023

Industry, Sector and Symbol

Industry
Electromedical equipment
Sub-Industry
Health Care Equipment
Sector
Medical
CUSIP
58505510
Employees
95,000
Year Founded
1949

Price Target and Rating

Average Stock Price Forecast
$117.13
High Stock Price Forecast
$165.00
Low Stock Price Forecast
$85.00
Forecasted Upside/Downside
+24.0%
Consensus Rating
Hold
Rating Score (0-4)
2.45
Research Coverage
22 Analysts

Profitability

Net Income
$5.04 billion
Pretax Margin
17.41%

Debt

Sales & Book Value

Annual Sales
$31.69 billion
Cash Flow
$7.72 per share
Book Value
$39.30 per share

Miscellaneous

Outstanding Shares
1,341,540,000
Free Float
1,335,234,000
Market Cap
$126.74 billion
Optionable
Optionable
Beta
0.75

Social Links


Key Executives














MDT Stock - Frequently Asked Questions

Should I buy or sell Medtronic stock right now?

22 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Medtronic in the last twelve months. There are currently 1 sell rating, 10 hold ratings and 11 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" MDT shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in MDT, but not buy additional shares or sell existing shares.
View MDT analyst ratings
or view top-rated stocks.

What is Medtronic's stock price forecast for 2022?

22 equities research analysts have issued 12 month price targets for Medtronic's shares. Their MDT share price forecasts range from $85.00 to $165.00. On average, they predict the company's stock price to reach $117.13 in the next year. This suggests a possible upside of 23.9% from the stock's current price.
View analysts price targets for MDT
or view top-rated stocks among Wall Street analysts.

How have MDT shares performed in 2022?

Medtronic's stock was trading at $103.45 at the start of the year. Since then, MDT shares have decreased by 8.6% and is now trading at $94.55.
View the best growth stocks for 2022 here
.

When is Medtronic's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, August 23rd 2022.
View our MDT earnings forecast
.

How can I listen to Medtronic's earnings call?

Medtronic will be holding an earnings conference call on Tuesday, August 23rd at 8:00 AM Eastern. Interested parties can register for or listen to the call using this link.

How were Medtronic's earnings last quarter?

Medtronic plc (NYSE:MDT) announced its earnings results on Thursday, May, 26th. The medical technology company reported $1.52 earnings per share for the quarter, missing analysts' consensus estimates of $1.56 by $0.04. The medical technology company had revenue of $8.09 billion for the quarter, compared to the consensus estimate of $8.43 billion. Medtronic had a net margin of 15.90% and a trailing twelve-month return on equity of 14.50%. Medtronic's quarterly revenue was down 1.2% compared to the same quarter last year. During the same quarter in the previous year, the company earned $1.50 EPS.
Read the conference call transcript
.

How often does Medtronic pay dividends? What is the dividend yield for Medtronic?

Medtronic announced a quarterly dividend on Wednesday, May 25th. Investors of record on Friday, June 24th will be paid a dividend of $0.68 per share on Friday, July 15th. This represents a $2.72 annualized dividend and a dividend yield of 2.88%. The ex-dividend date of this dividend is Thursday, June 23rd. This is an increase from the stock's previous quarterly dividend of $0.63.
Read our dividend analysis for MDT
.

Is Medtronic a good dividend stock?

Medtronic (NYSE:MDT) pays an annual dividend of $2.72 per share and currently has a dividend yield of 2.92%. The company has been increasing its dividend for 46 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio is 72.92%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, MDT will have a dividend payout ratio of 45.26% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for MDT.

What guidance has Medtronic issued on next quarter's earnings?

Medtronic updated its FY 2023 earnings guidance on Thursday, June, 23rd. The company provided EPS guidance of $5.53-$5.65 for the period, compared to the consensus EPS estimate of $5.82. The company issued revenue guidance of -.

What is Omar S. Ishrak's approval rating as Medtronic's CEO?

1,925 employees have rated Medtronic Chief Executive Officer Omar S. Ishrak on Glassdoor.com. Omar S. Ishrak has an approval rating of 92% among the company's employees. This puts Omar S. Ishrak in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Medtronic own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Medtronic investors own include Johnson & Johnson (JNJ), AT&T (T), NVIDIA (NVDA), AbbVie (ABBV), Walt Disney (DIS), Cisco Systems (CSCO), Intel (INTC), CVS Health (CVS), Home Depot (HD) and Walmart (WMT).

What is Medtronic's stock symbol?

Medtronic trades on the New York Stock Exchange (NYSE) under the ticker symbol "MDT."

Who are Medtronic's major shareholders?

Medtronic's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Lazard Asset Management LLC (1.20%), Swiss National Bank (0.43%), Sumitomo Mitsui Trust Holdings Inc. (0.34%), Principal Financial Group Inc. (0.30%), State Farm Mutual Automobile Insurance Co. (0.27%) and Envestnet Asset Management Inc. (0.22%). Insiders that own company stock include Bradley E Lerman, Brett A Wall, Brett A Wall, Carol A Surface, Carol A Surface, Geoffrey Martha, Hoedt Rob Ten, Hooman Hakami, John R Liddicoat, Karen L Parkhill, Karen L Parkhill, Michael J Coyle, Omar Ishrak, Richard H Anderson, Richard H Anderson, Richard Kuntz, Robert John White and Sean Salmon.
View institutional ownership trends
.

How do I buy shares of Medtronic?

Shares of MDT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Medtronic's stock price today?

One share of MDT stock can currently be purchased for approximately $94.55.

How much money does Medtronic make?

Medtronic (NYSE:MDT) has a market capitalization of $126.84 billion and generates $31.69 billion in revenue each year. The medical technology company earns $5.04 billion in net income (profit) each year or $3.73 on an earnings per share basis.

How many employees does Medtronic have?

The company employs 95,000 workers across the globe.

When was Medtronic founded?

Medtronic was founded in 1949.

How can I contact Medtronic?

Medtronic's mailing address is 20 ON HATCH LOWER HATCH STREET, DUBLIN L2, D02. The official website for the company is www.medtronic.com. The medical technology company can be reached via phone at (531) 438-1700, via email at investor.relations@medtronic.com, or via fax at 763-514-4879.

This page (NYSE:MDT) was last updated on 8/11/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.